General MedicationsORALGeneric
FLUXID
FAMOTIDINE
Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview FLUXID is listed in Drugs@FDA under application 021712 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient FAMOTIDINE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 20MG Sponsor UCB INC Submission history Latest submission status date: 2004-09-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUXID is listed in Drugs@FDA under application 021712 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FAMOTIDINE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 20MG Sponsor UCB INC Submission history Latest submission status date: 2004-09-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.